Home » SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
June 7, 2012
Stung by the chromium-contaminated drug capsule scandal, China’s State Food and Drug Administration (SFDA) is proposing to “blacklist” executives who oversee pharma companies found to produce substandard or counterfeit drugs.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor